The top ten global generics and biosimilars companies according to a recent Informa Pharma Intelligence ranking for 2019. Sandoz leads the way in terms of revenues from generics, biosimilars, APIs, and OTC drugs, followed by Mylan - which recently merged with Pfizer's Upjohn unit to form a new company, 'Viatris' - and then TEVA.   

Made with Visme Infographic Maker